Lilly Eli Co stock is traded at $1,411.95, with a volume of 3,761,010. It is up +4.28% in the last 24 hours and up +19.73% over the past month. Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
Previous Close:
$1,354.00
Open:
$1,365.40
24h Volume:
3,761,010
Relative Volume:
1.04
Market Cap:
$1.26T
Revenue:
$72.25B
Net Income/Loss:
$25.28B
P/E Ratio:
50.82
EPS:
$27.78
Net Cash Flow:
$10.37B
1W Performance:
+0.07%
1M Performance:
+19.73%
6M Performance:
+48.87%
1Y Performance:
+52.75%
1-Day Range:
$1,364.58$1,419.67
1-Week Range:
$1,333.22$1,453.00
52-Week Range:
$850.51$1,453.00
Lilly Eli Co Stock (LLY) Company Profile
Name
Lilly Eli CoSector
HealthcareIndustry
Drug Manufacturers - GeneralPhone
(317) 276-2000Address
LILLY CORPORATE CTR, INDIANAPOLIS, IN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS